Authors


Gina Battaglia

Latest:

Diagnosis and Treatment of Chronic Lyme Disease: A Complex Issue

Recognition of chronic Lyme disease and the role of long-term antibiotic treatment for persistent symptoms continue to be controversial among researchers, providers, patients, and advocates.


Laura Genn

Latest:

Effectiveness of Pertussis Vaccine May Wane Over Time, Study Shows

Kaiser Permanente Northern California’s study shows that the pertussis vaccine weakens as time passes after a patient's most recent vaccination.


Jenina Pellegren

Latest:

Pfizer Foundation Donates Millions to Help Combat Zika

The CDC Foundation and the Florida Department of Health have announced that the the Pfizer Foundation has donated millions to improve Zika response efforts.


Christina G. Rivera*, PharmD, BCPS, AAHIV-M

Latest:

Outpatient Antimicrobial Stewardship: Field of Dreams or Land of Opportunity for Pharmacists?

Relevant existing reports, though limited, demonstrated positive outcomes and suggest a promising space for pharmacy practice growth in outpatient antimicrobial stewardship.


KIMBERLY C. CLAEYS, PHARMD, BCPS*+

Latest:

Diagnostic Stewardship: Beyond Managing Bloodstream Infections

Diagnostic stewardship is a novel concept related to modifying the process of ordering, testing, and reporting with the goal of decreasing unnecessary testing and treatment, working upstream and synergistically with antimicrobial stewardship principles.


David A. Schwartz, MD, MS Hyg, FCAP

Latest:

COVID-19, SARS-CoV-2 and Pregnancy: Does the Past Predict the Present?

Preliminary evidence indicates no direct evidence for intrauterine transmission of the SARS-CoV-2 virus from pregnant women with COVID-19 to their infants.


TAYLOR MORRISETTE, PHARMD*+

Latest:

Bacteriophage-Antibiotic Combinations: A Promising Alternative for Refractory Infections?

Despite the initial abandonment of bacteriophages in most areas of the world, the era of antibiotic resistance has led to a resurgence of phage therapy in clinical practice.


Ahmed Babiker, MBBS

Latest:

Intravenous Fosfomycin for Systemic Multidrug-Resistant Infections

Intravenous (IV) fosfomycin offers a novel therapeutic option in the treatment of systemic multi-drug resistant (MDR) infections. Unanswered questions remain regarding its efficacy and specific role in our therapeutic arsenal.


Kyle Massey, PharmD

Latest:

Shoutout to the Stewards: Holiday Edition

Contagion® radio is here to bring joy with every new antibiotic alert!


JOSEPH KOHN, PHARMD

Latest:

Get Off the SOFA! Introducing the Quick Pitt Bacteremia Score

The quick Pitt Bacteremia Score offers accuracy comparable to the original version's across multiple infections, and maintains ease of use.


MelANIE T. MAHONEY, MPH, PHARMD STUDENT

Latest:

What's New From the CLSI Subcommittee on Antimicrobial Susceptibility Testing

Updates include novel and revised breakpoints for azithromycin, polymyxins, daptomycin, and cefiderocol.


Glenn Tillotson, PhD

Latest:

Pan-resistant, Currently Untreatable Gram-Negative Infections Come Closer to Home

The global emergence of antimicrobial resistance among gram-negative species is a major public health concern.


Ravina Kullar, PharmD, MPH, FIDSA*

Latest:

Investigational Treatments for Clostridioides difficile Infection

The high recurrence rates of Clostridioides difficile infection highlight the need for novel agents with unique mechanisms of action for treating the infection.


Jonna Lorenz

Latest:

Pandemic Disrupts Progress Toward Hepatitis B Control

Efforts to ramp up hepatitis B vaccination at birth and in infancy are crucial to controlling the disease in Africa, which accounted for 66% of new infections in 2019.


Joseph DeSimone Jr, MD

Latest:

What's in the Pipeline?

A look at up-and-coming HIV drugs in development.


Jessica Robinson, PharmD, BCPS

Latest:

A Long-Term Care Antimicrobial Stewardship Certificate Program for Pharmacists: Filling an Unmet Need

This training will empower pharmacists practicing in LTC facilities to develop antimicrobial stewardship programs, improve patient outcomes related to infectious diseases, and facilitate compliance with CMS requirements.



Caitlyn Fitzpatrick

Latest:

HCV Testing Remains Low Among High-Risk Population

When the US Preventive Services Task Force (USPSTF) recommended that all baby boomers undergo a one-time hepatitis C screening in 2013, testing prevalence increased. However, the rate is still lower than officials would like to see.


JOSE MAURO PERALTA, MD, PHD

Latest:

Is Investment in New Technologies for Diagnosing Schistosomiasis Justified in an Era of Schistosoma Elimination?

The emergence of new species creates pressure for developing affordable and reliable diagnostic strategies.


Meghan Jeffres, PharmD, BCIDP*

Latest:

Two Allergies or Cross-Reactive?

The story of penicillin and cefazolin.


William Perlman, PhD, CMPP

Latest:

CabA May Hold Key to Reducing Food-borne Illnesses Caused by Vibrio vulnificus

By targeting CabA, an extracellular matrix protein essential for biofilm formation, it may be possible to reduce the incidence of food-borne illnesses caused by the potentially lethal Vibrio vulnificus marine bacterium found in biofilms on oyster shells and meat.


Ariane van der Straten, PhD, MPH

Latest:

Implants for Delivery of Antiretroviral Drugs for HIV Pre-Exposure Prophylaxis

Implants are promising for long-term, sustained, and reversible delivery of ARV drugs that may bypass adherence challenges for end users.


Mike Hennessy, Sr, Chairman

Latest:

Reassessing Practices Is Critical During an Infectious Disease Outbreak

The constant reassessment of business practices is necessary to ensure that practitioners are not wasting valuable time, resources, and effort on activities that are not producing the desired results.


Jonathan Lapin, PharmD

Latest:

Role of Immunosuppression on Community-Acquired Clostridioides difficile Risk

CDI remains an urgent public health threat and continues to be the most frequent cause of diarrhea among hospitalized patients and overall hospital-acquired infection in the United States.


MONIQUE R. BIDELL, PHARMD, BCPS

Latest:

The Early Bird Gets to Stay Home: Early OPAT Follow-Up Reduces 30-Day Readmissions

Readmission rates for patients receiving OPAT are reported to be as high as 20%, mostly due to catheter-related problems, adverse drug reactions, or worsening of the primary infection.


P. BRANDON BOOKSTAVER, PHARMD*

Latest:

Get Off the SOFA! Introducing the Quick Pitt Bacteremia Score

The quick Pitt Bacteremia Score offers accuracy comparable to the original version's across multiple infections, and maintains ease of use.


JOHN CHAN, MD

Latest:

The Case of Late Aspergillus Fumigatus Infection of Implantable Cardioverter Defibrillator Leads

Quick action was needed against this very rare cause of fungal endocarditis.


Jason J. Schafer, PharmD, MPH, BCPS AQ-ID, AAHIVP

Latest:

The Power of PrEP

The results of a new study demonstrate that PrEP can reduce new infections within a population even when the risk of HIV remains high and other proven treatment and prevention strategies are optimized.


Bruce M. Jones, PharmD, BCPS

Latest:

Conversations Around Discharge and Potential Outpatient Treatment Follow-up

Jones offered his insights for discharging patients as well as follow-up outpatient treatment.


Shawn MacVane, PharmD

Latest:

Fluoroquinolone Antibiotics: More Recommendations for Prudent Use

Despite concerning findings and warnings, fluoroquinolones have remained one of the world’s most commonly prescribed antibiotic classes, with the United States accounting for more than 32 million prescriptions in 2015 alone.

© 2025 MJH Life Sciences

All rights reserved.